Table 2 Demographics, clinical syndrome and pathological subtypes assigned by 5 independent raters to FTLD-TDP cases in this study
Subtype | Case # | Age at death (y)/ Gender (M/F) | Disease duration (y) | Initial syndromes | pTDP43 | iTDP43 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Reviewer | Reviewer | ||||||||
| Â | Â | Â | Â | Â | 1 | 2 | 3 | 4 | 5 | 1 | 2 | 3 | 4 | 5 |
A | 1 | 76F | 2 | bvFTD | A | A | A | A | B | B | A | A | B | B |
A | 2 | 84F | 8 | Language FTD | C | A | A | C | C | A | A | A | C | A |
A | 3 | 54F | 6 | bvFTD | A | A | A | B | A | A | A | A | A | A |
A | 4 | 60M | 3 | Language FTD+bvFTD | A | A | A | A | A | A | A | A | A | A |
A | 5* | 72M | 9 | bvFTD | A | A | A | A | A | A | A | A | C | A |
A | 6* | 65M | 2 | bvFTD | A | C | A | C | A | A | C | C | B | A |
A | 7* | 65F | 3 | bvFTD + MND | B | A | B | A | A | B | A | B | B | B |
B | 8* | 55M | 3 | bvFTD | B | B | B | B | B | B | B | D | C | B |
B | 9 | 52F | 1 | bvFTD + MND | B | B | B | A | B | A | B | B | A | B |
B | 10 | 66M | 2 | bvFTD + MND | B | B | B | B | B | A | B | C | C | B |
B | 11 | 55F | 2 | bvFTD + MND | B | B | B | B | B | B | B | C | B | B |
C | 12 | 68F | 1 | Language FTD + MND | B | C | C | C | C | B | C | B | B | C |
C | 13 | 68M | 12 | bvFTD | C | C | C | C | C | C | C | C | C | C |
C | 14 | 83F | 13 | Language FTD | C | C | C | C | C | C | C | C | C | C |